CLASS III Device recall · Reported 30 Dec 2015 · FDA Enforcement Report

ProScreen 10 Panel Dip Card w/Adult recalled by Ameditech

Ameditech is recalling ProScreen 10 Panel Dip Card w/Adult, distributed nationwide in the US. The recall was initiated on 16 Nov 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codes144902 150474 151686 151687 152043 152225 152312 152402 152952 153306 153563 153663 153664 153665 153680 153682 153703 153704 153759 153760 153763 153852 153853
Quantity recalled1,989 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0519-2016
FDA event ID
72651
Recalling firm
Ameditech, San Diego, CA
Classification
Class III
Status
Terminated
Recall initiated
16 Nov 2015
FDA classified
24 Dec 2015
Reported
30 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

16 Nov 2015Recall initiated by company
24 Dec 2015Classified by FDA+38 days
30 Dec 2015Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Product as listed by the FDA

ProScreen 10 Panel Dip Card w/Adult, Item No. PSDA-10MO, PSDA-10MMO300, PSDA-10PPX, PSDA-10BUP, PSD-12BUP, PSD-10M, PSCupA-6MB-W, PSCup-10MMO300, PSD-5AB, PSD-10CMO3, PSCupA-10MO, PSCupA-12M-W I-DXA-1127-023, PSCupA-12TBU.

Where it was distributed

Nationwide Distribution.

Nationwide

Questions about this recall

Is ProScreen 10 Panel Dip Card w/Adult recalled?

Yes. Ameditech recalled ProScreen 10 Panel Dip Card w/Adult on 16 Nov 2015. The recall is Class III and its status is Terminated. Recall number Z-0519-2016.

Why was it recalled?

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Which lots are affected?

144902 150474 151686 151687 152043 152225 152312 152402 152952 153306 153563 153663 153664 153665 153680 153682 153703 153704 153759 153760 153763 153852 153853

Where was it sold?

Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ameditech

All 109

Other Other Medical Devices recalls

All 13,771